What is Liminatus Pharma, Inc. Class A Common Stock?
, a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 3.37M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.